申请人:SMITHKLINE BEECHAM CORP
公开号:WO2002040023A1
公开(公告)日:2002-05-23
A method for the treatment or prophylaxis of the common cold, or respiratory viral infection caused by human rhinovirus infection (HRV), other enteroviruses, coronavirus, influenza virus, parainfluenza virus, respiratory syncytial virus, or adenovirus infection in a human in need thereof, which method comprises administering to said human an effective amount of an NK3 antagonist.